OKOLICSANYI, STEFANO
 Distribuzione geografica
Continente #
NA - Nord America 5.074
EU - Europa 2.280
AS - Asia 1.941
SA - Sud America 357
AF - Africa 36
Continente sconosciuto - Info sul continente non disponibili 6
OC - Oceania 6
Totale 9.700
Nazione #
US - Stati Uniti d'America 4.959
SG - Singapore 746
CN - Cina 578
IT - Italia 415
DE - Germania 379
RU - Federazione Russa 343
SE - Svezia 297
BR - Brasile 280
HK - Hong Kong 247
IE - Irlanda 208
UA - Ucraina 171
GB - Regno Unito 146
VN - Vietnam 143
CA - Canada 88
IN - India 74
AT - Austria 67
DK - Danimarca 67
FI - Finlandia 49
FR - Francia 33
TR - Turchia 31
AR - Argentina 30
NL - Olanda 23
BE - Belgio 21
BD - Bangladesh 20
MX - Messico 19
KR - Corea 18
ES - Italia 16
ZA - Sudafrica 16
IQ - Iraq 15
EC - Ecuador 13
PL - Polonia 12
JP - Giappone 11
CO - Colombia 7
SA - Arabia Saudita 7
VE - Venezuela 7
ID - Indonesia 6
IR - Iran 6
CL - Cile 5
MA - Marocco 5
AE - Emirati Arabi Uniti 4
CZ - Repubblica Ceca 4
JO - Giordania 4
PE - Perù 4
PK - Pakistan 4
PY - Paraguay 4
TW - Taiwan 4
AU - Australia 3
BG - Bulgaria 3
BO - Bolivia 3
CH - Svizzera 3
DZ - Algeria 3
EU - Europa 3
HU - Ungheria 3
JM - Giamaica 3
KE - Kenya 3
LT - Lituania 3
MY - Malesia 3
NO - Norvegia 3
NZ - Nuova Zelanda 3
TN - Tunisia 3
UY - Uruguay 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AZ - Azerbaigian 2
BH - Bahrain 2
EG - Egitto 2
MD - Moldavia 2
OM - Oman 2
PH - Filippine 2
PT - Portogallo 2
QA - Qatar 2
RS - Serbia 2
SC - Seychelles 2
TH - Thailandia 2
A1 - Anonimo 1
AL - Albania 1
BB - Barbados 1
BY - Bielorussia 1
CR - Costa Rica 1
CY - Cipro 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GI - Gibilterra 1
GR - Grecia 1
GT - Guatemala 1
HN - Honduras 1
IL - Israele 1
KW - Kuwait 1
LB - Libano 1
LI - Liechtenstein 1
LU - Lussemburgo 1
ME - Montenegro 1
MN - Mongolia 1
NP - Nepal 1
RO - Romania 1
SR - Suriname 1
SY - Repubblica araba siriana 1
UZ - Uzbekistan 1
Totale 9.700
Città #
Ann Arbor 862
Woodbridge 462
Ashburn 422
Singapore 417
Fairfield 339
Houston 297
Chandler 271
Hong Kong 247
Wilmington 231
Frankfurt am Main 207
Dublin 201
Dearborn 166
Jacksonville 157
New York 139
Seattle 136
Cambridge 133
Milan 116
Beijing 89
Dallas 83
Princeton 81
Santa Clara 73
Vienna 65
Nanjing 64
Los Angeles 59
Shanghai 53
The Dalles 44
Altamura 39
Lawrence 38
Buffalo 33
Ho Chi Minh City 33
Moscow 30
Hanoi 28
Rome 28
Lachine 26
Guangzhou 23
Columbus 22
Council Bluffs 22
Tianjin 22
Nanchang 21
Shenyang 21
São Paulo 21
Dong Ket 18
San Diego 18
Boston 17
Chicago 16
Fremont 16
Helsinki 16
Munich 16
Ottawa 16
San Jose 16
Brussels 15
Hefei 15
Orem 15
Jinan 14
Toronto 14
Boardman 13
Andover 12
Brooklyn 12
Kunming 12
Phoenix 12
Edmonton 11
Lissone 11
London 11
Manchester 11
Rio de Janeiro 11
Changsha 10
Mountain View 10
Nürnberg 10
Warsaw 10
Johannesburg 9
Zhengzhou 9
Falls Church 8
Hangzhou 8
Hebei 8
Jiaxing 8
Mexico City 8
Salt Lake City 8
Seoul 8
Tokyo 8
Da Nang 7
Ningbo 7
Sacramento 7
Valencia 7
Atlanta 6
Brasília 6
Buenos Aires 6
Busto Arsizio 6
Chennai 6
Denver 6
Dhaka 6
Haiphong 6
Kiev 6
Pune 6
Taizhou 6
Washington 6
Ankara 5
Baghdad 5
Guayaquil 5
Quito 5
San Francisco 5
Totale 6.406
Nome #
Impact of multidisciplinary team approach to liver tumors: 5-Years experience 468
Impact of multidisciplinary team approach to liver tumors in a tertiary center: 5-years experience 439
Clinical outcome indicators in chronic hepatitis B and C: A primer for value-based medicine in hepatology 399
Optimising the clinical strategy for autoimmune liver diseases: Principles of value-based medicine 336
Diagnostic Value of Quantitative Perfusion Computed Tomography Technique in the Assessment of Tumor Response to Sorafenib in Patients with Advanced Hepatocellular Carcinoma 327
Diagnostic value of dynamic contrast-enhanced CT with perfusion imaging in the quantitative assessment of tumor response to sorafenib in patients with advanced hepatocellular carcinoma: A feasibility study 285
Value-based outcome indicators in the management of hepatocellular carcinoma: Clinical test in a large multicenter study (VBMH study) 278
Health related quality of life in chronic liver diseases 277
Dynamic contrast enhanced perfusion CT imaging: A diagnostic biomarker tool for survival prediction of tumour response to antiangiogenetic treatment in patients with advanced HCC lesions 273
Generation and performance of value-based outcome indicators in liver disease: The multicenter V.B.M.H. study 265
Outcome indicators in liver cirrhosis: Application of value-based medicine in a large multicenter study (VBMH study) 261
Mammalian target of rapamycin regulates vascular endothelial growth factor-dependent liver cyst growth in polycystin-2-defective mice 258
P1169 : Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 255
Outcome indicators in primary sclerosing cholangitis: Interim analysis of the value-based medicine in hepatology study 253
Outcome Indicators in Primary Sclerosing Cholangitis: Interim Analysis Of The Value-Based Medicine In Hepatology (VBMH) Study 251
P0811 : Sofosbuvir-based direct-acting antivirals treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 250
The impact of liver disease on the health-related quality of life 246
Value-based outcome indicators in liver cirrhosis: validation in a large multicenter study (VBMH study) 245
Direct-acting antivirals combination for elderly patients with chronic hepatitis C: A cost-effectiveness analysis 244
Characteristics of patients with Chronic Hepatitis C who have failed past treatment or who have never been treated: How much room left for Interferon? 243
Generation and Performance of Outcome Indicators in Liver Cirrhosis: The Value Based Medicine in Hepatology Study (V.B.M.H.) 236
Health Related Quality of Life in the Major Liver Conditions 236
Measurement of clinical outcomes and quality of life indicators as a new value-based approach to liver cirrhosis management 235
The Impact of Type of Liver Conditions on the Patients’ Health Related Quality of Life 227
A Comparison Between The Health-Related Quality Of Life Reported By The General Population And By Patients With Major Liver Diseases 227
A value-based approach to the management of patients with liver cirrhosis through the systematic measurement of clinical outcome and quality of life indicators 219
Liver-allocation policies for patients affected by HCC in Europe 219
Impatto dei farmaci anti virali ad azione diretta sulla cura dei pazienti con epatite C: un approccio di value-based medicine 219
Sofosbuvir-based all-oral treatment for elderly chronic hepatitis C patients: A cost-effectiveness analysis 217
Management of treatment-naïve chronic hepatitis C genotype 1 patients: A cost-effectiveness analysis of treatment options 214
PGI36 Relationship Between Clinical Severity and Health Related Quality of Life in Chronic Liver Diseases 211
Difference in health related quality of life of chronic liver diseases and general population 210
Value-based approach to hepatocellular carcinoma: outcome indicators tested in a large multicenter study (VBMH study) 209
Sorafenib paradoxically activates the raf/mek/erk signaling in mice with polycystic liver disease (pld) caused by conditional deletion of polycystin-2 208
PGI31 Health Care Indicators to Measure Quality of Care in Patients with Liver Diseases 206
Cyclic AMP/PKA-dependent paradoxical activation of Raf/MEK/ERK signaling in polycystin-2 defective mice treated with sorafenib 203
Surgical management of hepatocellular carcinoma within and beyond BCLC indications in a middle volume center 201
Management of chronic hepatitis C (Chc) genotype 1 treatment-naïve patients in an era of rising opportunities and costs: A cost-effectiveness analysis 183
Applicazione della value-based medicine nella valutazione della cura dei pazienti affetti da epatite. 179
Is the risk of neoplastic recurrence increased after prescribing direct-acting antivirals for HCV patients whose HCC was previously cured? 165
Totale 10.077
Categoria #
all - tutte 32.163
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 32.163


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021442 0 0 0 0 0 0 59 85 77 83 59 79
2021/2022551 51 59 72 57 16 41 19 41 26 37 38 94
2022/20231.054 106 369 88 90 56 139 21 73 68 3 31 10
2023/2024647 21 27 15 49 58 213 127 24 40 6 5 62
2024/20251.504 86 160 115 47 123 59 99 49 196 260 109 201
2025/20261.880 472 158 303 325 422 187 13 0 0 0 0 0
Totale 10.077